Stated Preferences for Systemic Treatments for Prostate Cancer: A Targeted Review of the Discrete-Choice Experiment Literature
Despite differences in safety and tolerability attribute rankings among respondents across earlier-stage and late-stage PC treatments, efficacy outcomes were most important to patients and HCPs.
Authors
- Verity Watson
- Agnes Hong
- Michael Ryan
- David Russell
- Neeraj Agarwal
- Brett Hauber
- Savanna Darnell
- Joshua Coulter
- Sean P. Collins
Institutions
- Pfizer (United States) (US)
- University of Aberdeen (GB)
- University of Utah (US)
- University of South Florida (US)
- Huntsman Cancer Institute (US)
Publication Details
- Journal
- Patient
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1007/s40271-026-00811-8
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00